In vitro preliminary studies of chitooligosaccharide coated nanostructured lipidic nanoparticles for efficient gene delivery

Year 2019, Volume: 23 Issue: 4, 671 - 681, 27.06.2025

Behiye Şenel

Abstract

Gene therapy is generally defined as the transfer of genetic material to cells to treat a disease or at least improve the clinical condition of a patient. The most commonly used vectors in gene therapy are viral and non-viral vectors. The aim of this study was to develop a gene carrier system based on chitooligosaccharide-coated nanostructured lipidic nanoparticles and evaluate the physicochemical properties, such as zeta potential, particle size, SEM images, pH, cytotoxicity, DNA-binding properties, serum stability and transfection to cells. In this study, cationic formulations were produced using Dynasan® 116 and Transcutol ®P as a lipidic phase and chitooligosaccharide lactate for polymeric coating with DOTAP as a cationic agent. These formulations were made with the oil-in water hot emulsification technique. GFP was selected as the genetic material to be loaded into the formulations. According to the results, the chitooligosaccharide-coated cationic lipid nanoparticles prepared had considerably small particle sizes (144- 178 nm) and high zeta potential (+37.6/+33.7mV). Based on the MTT assay, the cytotoxic effect of formulations on the NIH 3T3, A549 and MDA-MB-231 cell lines exhibited a dose-time-dependant pattern. Further, the prepared formulations binded DNA effectively and protected DNA against the serum component. It was concluded that chitooligosaccharide-coated lipidic nanoparticle formulations can be prepared as a pDNA-nanoparticle complex and can be employed as a gene delivery system effectively.

Keywords

Chitooligosaccharide lactate , lipidic nanocarrier , gene delivery , cytotoxicity , transfection.

References

• [1] Bhatia S. Chapter 3: Chitosan based nanomaterials and its applications. In: Systems for Drug Delivery: Safety, Animal and Microbial Polysaccharides. Springer, Netherland, 2016, pp. 55–117. [CrossRef]
• [2] Pozo-Rodríguez A, Solinís MA, Rodríguez-Gascón A. Applications of lipid nanoparticles in gene therapy. Eur J Pharm Biopharm. 2016; 109: 184–193. [CrossRef]
• [3] Souto EB, Wissing SA, Barbos CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004; 278: 71–77. [CrossRef]
• [4] Patidar A, Thakur DS, Kumar P, Verma J. A review on novel lipid based nanocarriers. Int J Pharm Sci. 2010; 2(4): 30–35.
• [5] Demirel M, Yazan Y. Katı lipit nanopartiküller (SLN). FABAD J Pharm Sci. 2000; 25: 167–179.
• [6] Mehnert W, Mäder K. Solid lipid nanoparticles: Production characterization and applications. Adv Drug Deliver Rev. 2001; 47: 165–196. [CrossRef]
• [7] Saupe A, Rades T. Chapter 3: Solid lipid nanoparticles. In: Mozafari MR (Ed.), Nanocarrier Technologies, Frontiers of Nanotherapy. Springer, Netherland, 2006, pp. 41–43.
• [8] Numanoğlu U, Tarımcı N. Katı lipid nanopartiküllerin (SLNTM) özellikleri, farmasötik ve kozmetik alandaki uygulamaları. Ankara Ecz Fak Derg. 2006; 35(3): 211–235.
• [9] Tamjidi F, Shahedi M, Varshosaz J, Nasirpour A. Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innov Food Sci Emerg Tech. 2013; 19(0): 29–43. [CrossRef]
• [10] Kaur S, Nautyal U, Singh R, Singh S, Devi A. Nanostructure Lipid Carrier (NLC): the new generation of lipid nanoparticles. Asian Pac J Health Sci. 2015; 2(2): 76–93.
• [11] Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009; 366(1–2): 170–184. [CrossRef]
• [12] Beloqui A, Solinís MÁ, des Rieux A, Préat V, Rodríguez-Gascón A. Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs. Int J Pharm. 2014; 468(1–2): 105–111. [CrossRef]
• [13] Lodhi G, Kim YS, Hwang JW, et al. Chitooligosaccharide and its derivatives: Preparation and biological applications. Biomed Res Int. 2014; 2014: 1–13. [CrossRef]
• [14] Park PJ, Je JY, Kim SK. Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. J Agric Food Chem. 2003; 51(16): 4624–4627. [CrossRef]
• [15] Feng J, Zhao L, Yu Q. Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem Biophys Res Commun. 2004; 317(2): 414–420. [CrossRef]
• [16] Huang R, Mendis E, Rajapakse N, Kim SK. Strong electronic charge as an important factor for anticancer activity of chitooligosaccharides (COS). Life Sci. 2006; 78(20): 2399–2408. [CrossRef]
• [17] Ouyang QQ, Zhao S, Li SD, Song C. Application of chitosan, chitooligosaccharide, and their derivatives in the treatment of Alzheimer’s disease. Mar Drugs. 2017; 15(11): 1–15. [CrossRef]
• [18] Soma D, Attari Z, Reddy MS, et al. Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies. Braz J Pharm Sci. 2017; 53(1): 1–10. [CrossRef]
• [19] Şenel B, Büyükköroğlu G, Yazan Y. Solid lipid and chitosan particulate systems for delivery of siRNA. Pharmazie. 2015; 70: 698–705.
• [20] Baghdan E, Pinnapireddy SR, Strehlow B, et al. Lipid coated chitosan-DNA nanoparticles for enhanced gene delivery. Int J Pharm. 2018; 535(1–2): 473–479. [CrossRef]
• [21] Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems - a review (part 1). Trop J Pharm Res. 2013; 12(2): 255–264. [CrossRef]
• [22] Heydenreich AV, Westmeier R, Pedersen N, et al. Preparation and purification of cationic solid lipid nanospheres: effects on particle size, physical stability and cell toxicity. Int J Pharm. 2003; 254: 83–87. [CrossRef]
• [23] Rizvi SAA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018; 26(1): 64–70. [CrossRef]
• [24] Gratton SE, Ropp PA, Pohlhaus PD, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A. 2008; 105: 11613–11618. [CrossRef]
• [25] Foroozandeh P, Aziz A. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res Lett. 2018; 13: 339. [CrossRef]
• [26] Prabha S, Arya G, Chandra R, et al. Effect of size on biological properties of nanoparticles employed in gene delivery. Artif Cells Nanomed Biotechnol. 2016; 44(1): 83–91. [CrossRef]
• [27] Komatsu H, Kitajima A, Okada S. Pharmaceutical characterization of commercially available intravenous fat emulsions: Estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pharm Bull. 1995; 43: 1412–1415.
• [28] Shi L, Li Z, Yu L, et al. Effects of surfactants and lipids on the preparation of solid lipid nanoparticles using double emulsion method. J Dispers Sci Technol. 2011; 32: 1–9. [CrossRef]
• [29] Zhdanov RI, Podobed OV, Vlassov VV. Cationic lipid DNA complexes (lipoplexes) for gene transfer and therapy. Bioelectroch. 2002; 58(1): 53–64. [CrossRef]
• [30] Büyükköroğlu G. Development of solid lipid nanoparticles as gene delivery system. Turk J Pharm Sci. 2016; 13(2): 169–181. [CrossRef]
• [31] Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012; 14(1): 1–16. [CrossRef]
• [32] Rao NM. Cationic lipid-mediated nucleic acid delivery: Beyond being cationic. Chem Phys Lipids. 2010; 163: 245–252. [CrossRef]
• [33] Kumari M, Liu CH, Wu WC. Efficient gene delivery by oligochitosan conjugated serum albumin: Facile synthesis, polyplex stability, and transfection. Carbohydr Polym. 2018; 183(1): 37–49. [CrossRef]
• [34] Han Y, Li Y, Zhang P, et al. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy. Pharm Dev Technol. 2016; 21(3): 277–281. [CrossRef]
• [35] Heinz H, Pramanik C, Heinz O, et al. Nanoparticle decoration with surfactants: Molecular interactions, assembly, and applications. Surf Sci Rep. 2017; 72(1): 1–58. [CrossRef]
• [36] Tojo C, Dios M, Barroso F. Surfactant effects on microemulsion-based nanoparticle synthesis. Materials. 2011; 4: 55–72. [CrossRef]
• [37] Anand K, Varghese S. Role of surfactants on the stability of nano-zinc oxide dispersions. Particul Sci Technol. 2017; 35(1): 67–70. [CrossRef]
• [38] Morsy SM. Role of surfactants in nanotechnology and their applications. Int J Curr Microbiol App Sci. 2014; 3(5): 237–260.
• [39] Olbrich C, Bakowsky U, Lehr CM, Müller RH, Kneue C. Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Release. 2001; 77(3): 345–355. [CrossRef]
• [40] Gencer S, Cebeci A, Irmak-Yazicioglu MB. Silencing of the MMP-3 gene by siRNA transfection in gastric cancer AGS cells. J Gastrointestin Liver Dis. 2011; 20: 19–26.